1210761-36-6

Basic information

• Product Name: methyl 2-(3-(4-(6-fluorobenzo[d]thiazol-2-yloxy)phenyl)isoxazole-5-carboxamido)-3-methylbutanoate
• Synonyms: methyl 2-(3-(4-(6-fluorobenzo[d]thiazol-2-yloxy)phenyl)isoxazole-5-carboxamido)-3-methylbutanoate
• CAS NO: 1210761-36-6
• Molecular Weight: 469.493
• Mol File: 1210761-36-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-(3-(4-(6-fluorobenzo[d]thiazol-2-yloxy)phenyl)isoxazole-5-carboxamido)-3-methylbutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(3-(4-(6-fluorobenzo[d]thiazol-2-yloxy)phenyl)isoxazole-5-carboxamido)-3-methylbutanoate(1210761-36-6)
• EPA Substance Registry System: methyl 2-(3-(4-(6-fluorobenzo[d]thiazol-2-yloxy)phenyl)isoxazole-5-carboxamido)-3-methylbutanoate(1210761-36-6)

Safety Data

• Hazardous Substances Data: 1210761-36-6(Hazardous Substances Data)

Upstream product

• 399-74-6 2-chloro-6-fluorobenzothiazole 
• 1210761-22-0 methyl 2-(3-(4-hydroxyphenyl)isoxazole-5-carboxamido)-3-methylbutanoate 

Downstream Products

• 1210761-37-7 2-(3-(4-(6-fluorobenzo[d]thiazol-2-yloxy)phenyl)isoxazole-5-carboxamido)-3-methylbutanoic acid 

Relevant articles and documents

OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS

The present invention relates to isoxazole, thiazole and oxidiazole derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments, in particular to the use of these compounds in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1.